KGP-25 is an inhibitor of voltage-gated sodium channel 1.8 (Nav1.8), which can be used for analgesia by targeting Nav1.8 in the peripheral nervous system (PNS). KGP-25 can also target gamma-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for general anesthesia[1].
Molekulargewicht:
357.92
Reinheit:
95
Formel:
C19H32ClNO3
Target-Kategorie:
GABA Receptor,Sodium Channel
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten